The stimulatory effect of insulin-like growth factor-1 on the proliferation, differentiation, and mineralisation of osteoblastic cells from Holstein cattle

Bellows, 1986, Mineralised bone nodules formed in vitro from enzymatically released rat calvaria cell populations, Calcified Tissue International, 38, 143, 10.1007/BF02556874 Canalis, 1988, Isolation of growth factors from adult bovine bone, Calcified Tissue International, 43, 346, 10.1007/BF02553277 Chang, 2000, Calcium and phosphate supplementation promotes bone cell mineralisation: implications for hydroxyapatite (HA)-enhanced bone formation, Journal of Biomedical Materials Research, 52, 270, 10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO;2-1 Collignon, 1997, Isolation of cells from ovine fetal long bone and characterisation of their osteoblastic activities during in vitro mineralisation, Archives of Physiology and Biochemistry, 105, 158, 10.1076/apab.105.2.158.12924 Cramer, 1973, The Giemsa stain for tissue sections: an improved method, American Journal of Clinical Pathology, 60, 148, 10.1093/ajcp/60.2.148 Davicco, 1992, Plasma osteocalcin concentrations in cows around parturition. The influence of a regular versus a very short dry period, Reproduction, Nutrition, Development, 32, 313, 10.1051/rnd:19920401 Delaney, 1994, Cellular and clinical perspectives on skeletal insulin-like growth factor-1, Journal of Cellular Biochemistry, 55, 328, 10.1002/jcb.240550309 Delmas, 1990, Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease, Endocrinology and Metabolism Clinics of North America, 19, 1, 10.1016/S0889-8529(18)30336-0 Delmas, 1993, Biochemical markers of bone turnover, Journal of Bone and Mineral Research, 8, S549, 10.1002/jbmr.5650081323 Eriksen, 1993, Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry, Journal of Bone and Mineral Research, 8, 127, 10.1002/jbmr.5650080202 Ernst, 1990, Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3, Endocrinology, 127, 807, 10.1210/endo-127-2-807 Fiedler, 2006, IGF-1 and IGF-2 stimulate directed cell migration of bone-marrow-derived human mesenchymal progenitor cells, Biochemical and Biophysical Research Communications, 345, 1177, 10.1016/j.bbrc.2006.05.034 Garnero, 1993, Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease, Journal of Clinical Endocrinology and Metabolism, 77, 1046 Goad, 1996, Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I, Endocrinology, 137, 2262, 10.1210/endo.137.6.8641174 Goff, 2000, Pathophysiology of calcium and phosphorus disorders: veterinary clinics of North America, Food Animal Practice, 16, 319, 10.1016/S0749-0720(15)30108-0 Hanai, 2006, Involvement of p44/p42 MAP kinase in insulin-like growth factor-1 induced alkaline phosphatase activity in osteoblast-like-MC3T3-E1 cells, Molecular and Cellular Endocrinology, 251, 42, 10.1016/j.mce.2006.02.014 Hauschka, 1986, Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin sepharose, Journal of Biological Chemistry, 261, 12665, 10.1016/S0021-9258(18)67143-1 He, 2006, Postnatal growth and bone mass in mice with IGF-1 haploinsufficiency, Bone, 38, 826, 10.1016/j.bone.2005.11.021 Hill, 1997, Multiple extracellular signals promote osteoblast survival and apoptosis, Endocrinology, 138, 3849, 10.1210/endo.138.9.5370 Hsu, 2007, Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated protein kinase pathway, Biochemical Pharmacology, 73, 504, 10.1016/j.bcp.2006.10.020 Ishizuya, 1997, Parathyroid hormone exerts disparate effects on osteoblast differentiation on exposure time in rat osteoblastic cells, Journal of Clinical Investigation, 99, 2961, 10.1172/JCI119491 Jia, 2003, Daidzein enhances osteoblast growth that may be mediated by increased bone morphogenetic protein (BMP) production, Biochemical Pharmacology, 65, 709, 10.1016/S0006-2952(02)01585-X Jiang, 2006, Transgenic mice with osteoblast-targeted insulin-like growth factor-1 show increased bone remodeling, Bone, 39, 494, 10.1016/j.bone.2006.02.068 Jilka, 1998, Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines, Journal of Bone Mineral Research, 13, 793, 10.1359/jbmr.1998.13.5.793 Kudo, 1998, Evidence for modulation of osteocalcin containing gamma-carboxyglutamic acid residues synthesis by insulin-like growth factor-1 and vitamin K2 in human osteosarcoma cell line MG-63, European Journal of Endocrinology, 138, 443, 10.1530/eje.0.1380443 Langdahl, 1998, The effects of IGF-1 and IGF-2 on proliferation and differentiation of human osteoblasts and interactions with growth hormone, European Journal of Clinical Investigation, 28, 176, 10.1046/j.1365-2362.1998.00265.x Li, 2002, Effects of genistein on proliferation, differentiation, content of matrix calcium and mineralisation of cultured osteoblasts in vitro, Chinese Journal of Osteoporosis, 8, 307 Li, 1996, Diagnose and treatment of osteomalacia of dairy cow, Chinese Journal of Veterinary Medicine, 22, 27 Mackie, 2003, Osteoblasts: novel roles in orchestration of skeletal architecture, The International Journal of Biochemistry and Cell Biology, 35, 1301, 10.1016/S1357-2725(03)00107-9 Malyszko, 2003, Osteoprotegerin and its correlations with new markers of bone formation and bone resorption in kidney transplant recipients, Transplantation Proceedings, 35, 2227, 10.1016/S0041-1345(03)00755-3 Melissa, K., 2007. Calcium metabolism and metabolic bone disease. Herp Care Collection, April, 2007. http://www.anapsid.org/mbd2.html (accessed 01.04.2007). Patel, 1993, Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use, Drugs, 46, 594, 10.2165/00003495-199346040-00003 Peterson, 1987, A method to assess the proliferating activity of small numbers of murine peripheral blood mononuclear cells, Journal of Immunological Methods, 96, 171, 10.1016/0022-1759(87)90311-5 Sara, 1990, Insulin-like growth factors and their binding proteins, Physiological Reviews, 70, 591, 10.1152/physrev.1990.70.3.591 Scheven, 1991, Effects of recombinant human insulin-like growth factor I and II (IGF-I/-II) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells, Growth Regulation, 1, 160 Seyedin, 1985, Purification and characterisation of two cartilage-inducing factors from bovine demineralised bone, Proceedings of the National Academy of Sciences of the USA, 82, 2267, 10.1073/pnas.82.8.2267 Staal, 1998, Regulation of osteocalcin production and bone resorption by 1,25 dihydroxyvitamin D3 in mouse long bone interaction with the bone-derived growth factors TGF-beta and IGF-1, Journal of Bone and Mineral Research, 13, 36, 10.1359/jbmr.1998.13.1.36 Suh, 2007, Stimulative effects of Ulmus davidiana Planch (Ulmaceae) on osteoblastic MC3T3-E1 cells, Journal of Ethnopharmacology, 109, 480, 10.1016/j.jep.2006.08.030 Yang, 2007, Establishment and characterisation of a human telomerase catalytic subunit-transduced fetal bone marrow-derived osteoblastic cell line, Differentiation, 75, 24, 10.1111/j.1432-0436.2006.00111.x Yeh, 2006, Co-transfection with the osteogenic protein (OP)-1 gene and the insulin-like growth factor (IGF)-1 gene enhanced osteoblastic cell differentiation, Biochimica et Biophysica Acta – Molecular Cell Research, 1763, 57, 10.1016/j.bbamcr.2005.11.001 Yeh, 1997, Osteogenic protein-1 and insulin-like growth factor-1 synergistically stimulate rat osteoblastic cell differentiation and proliferation, Endocrinology, 138, 4181, 10.1210/endo.138.10.5465 Zhang, 2003, The expression of insulin-like growth factor-1 mRNA and polypeptide in rat osteoblasts with exposure to parathyroid hormone, Chinese Medical Journal, 116, 1916